Patents by Inventor Jelena Janjic

Jelena Janjic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
    Patent number: 9352057
    Abstract: The disclosure provides, in part, compositions and methods for producing emulsions. In certain embodiments, emulsions of the disclosure can be used for the detection of inflammation and cell tracking using MRI. The disclosure provides, in part, methods for labeling, detecting and quantifying cell members, in vivo. In certain embodiments, emulsions can be used as an artificial blood substitute.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: May 31, 2016
    Assignee: Celsense, Inc.
    Inventors: Eric T. Ahrens, Jelena Janjic
  • COMPOSITIONS AND METHODS FOR PRODUCING EMULSIONS FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES AND OTHER APPLICATIONS
    Publication number: 20130343999
    Abstract: The disclosure provides, in part, compositions and methods for producing emulsions. In certain embodiments, emulsions of the disclosure can be used for the detection of inflammation and cell tracking using MRI. The disclosure provides, in part, methods for labeling, detecting and quantifying cell members, in vivo. In certain embodiments, emulsions can be used as an artificial blood substrate.
    Type: Application
    Filed: May 24, 2013
    Publication date: December 26, 2013
    Applicant: Celsense, Inc.
    Inventors: Eric T. Ahrens, Jelena Janjic
  • Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
    Patent number: 8227610
    Abstract: The disclosure provides, in part, compositions of perfluoro polyether compounds and associated methods for producing cellular labels for tracking cells by MRI and methods for labeling, detecting and quantifying cell numbers in vivo.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: July 24, 2012
    Assignee: Carnegie Mellon University
    Inventors: Jelena Janjic, Eric T. Ahrens
  • COMPOSITIONS AND METHODS FOR PRODUCING EMULSIONS FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES AND OTHER APPLICATIONS
    Publication number: 20110110863
    Abstract: The disclosure provides, in part, compositions and methods for producing emulsions. In certain embodiments, emulsions of the disclosure can be used for the detection of inflammation and cell tracking using MRI. The disclosure provides, in part, methods for labeling, detecting and quantifying cell numbers in vivo.
    Type: Application
    Filed: May 1, 2009
    Publication date: May 12, 2011
    Applicant: CELSENSE, INC.
    Inventors: Eric T. Ahrens, Jelena Janjic
  • Analogs of leucascandrolide A
    Patent number: 7569594
    Abstract: The present invention describes leucascandrolide analogs of the formula (I), intermediates of the formula (III), pharmaceutical compositions containing the same, methods for preventing cell proliferation, and methods for treating cancers and other proliferative diseases.
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: August 4, 2009
    Assignee: The University of Chicago
    Inventors: Sergey A. Kozmin, Jelena Janjic
  • Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
    Publication number: 20090074673
    Abstract: The disclosure provides, in part, compositions and methods for producing cellular labels for tracking cells by MRI. The disclosure provides, in part, methods for labeling, detecting and quantifying cell numbers in vivo.
    Type: Application
    Filed: July 10, 2008
    Publication date: March 19, 2009
    Applicant: Carnegie Mellon University
    Inventors: Jelena Janjic, Eric T. Ahrens
  • Analogs of leucascandrolide A
    Publication number: 20060178355
    Abstract: The present invention describes leucascandrolide analogs of the formula (I), intermediates of the formula (III), pharmaceutical compositions containing the same, methods for preventing cell proliferation, and methods for treating cancers and other proliferative diseases.
    Type: Application
    Filed: February 7, 2006
    Publication date: August 10, 2006
    Inventors: Sergey Kozmin, Jelena Janjic